310 related articles for article (PubMed ID: 26005835)
1. RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growth.
Depeille P; Henricks LM; van de Ven RA; Lemmens E; Wang CY; Matli M; Werb Z; Haigis KM; Donner D; Warren R; Roose JP
Nat Cell Biol; 2015 Jun; 17(6):804-15. PubMed ID: 26005835
[TBL] [Abstract][Full Text] [Related]
2. RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.
Gbenedio OM; Bonnans C; Grun D; Wang CY; Hatch AJ; Mahoney MR; Barras D; Matli M; Miao Y; Garcia KC; Tejpar S; Delorenzi M; Venook AP; Nixon AB; Warren RS; Roose JP; Depeille P
JCI Insight; 2019 Jun; 5(15):. PubMed ID: 31237864
[TBL] [Abstract][Full Text] [Related]
3. Deconstructing Ras signaling in the thymus.
Kortum RL; Sommers CL; Pinski JM; Alexander CP; Merrill RK; Li W; Love PE; Samelson LE
Mol Cell Biol; 2012 Jul; 32(14):2748-59. PubMed ID: 22586275
[TBL] [Abstract][Full Text] [Related]
4. A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab.
Lee SK; Cho YH; Cha PH; Yoon JS; Ro EJ; Jeong WJ; Park J; Kim H; Il Kim T; Min DS; Han G; Choi KY
Exp Mol Med; 2018 Nov; 50(11):1-12. PubMed ID: 30459318
[TBL] [Abstract][Full Text] [Related]
5. Nras Q61R/+ and Kras-/- cooperate to downregulate Rasgrp1 and promote lympho-myeloid leukemia in early T-cell precursors.
Wen Z; Yun G; Hebert A; Kong G; Ranheim EA; Finn R; Rajagoplan A; Li S; Zhou Y; Yu M; Damnernsawad A; Roose JP; Coon JJ; Wen R; Wang D; Zhang J
Blood; 2021 Jun; 137(23):3259-3271. PubMed ID: 33512434
[TBL] [Abstract][Full Text] [Related]
6. Translational relevance of SOS1 targeting for KRAS-mutant colorectal cancer.
Alem D; Yang X; Beato F; Sarcar B; Tassielli AF; Dai R; Hogenson TL; Park MA; Jiang K; Cai J; Yuan Y; Fernandez-Zapico ME; Tan AC; Fleming JB; Xie H
Mol Carcinog; 2023 Jul; 62(7):1025-1037. PubMed ID: 37042566
[TBL] [Abstract][Full Text] [Related]
7. Sos1 regulates sustained TCR-mediated Erk activation.
Poltorak M; Meinert I; Stone JC; Schraven B; Simeoni L
Eur J Immunol; 2014 May; 44(5):1535-40. PubMed ID: 24497027
[TBL] [Abstract][Full Text] [Related]
8. Unexpected insights for anti-EGFR cancer therapy.
Depeille P; Warren RS; Roose JP
Oncotarget; 2015 Aug; 6(22):18746-7. PubMed ID: 26300054
[No Abstract] [Full Text] [Related]
9. RasGRP1 promotes the acute inflammatory response and restricts inflammation-associated cancer cell growth.
Wang C; Li X; Xue B; Yu C; Wang L; Deng R; Liu H; Chen Z; Zhang Y; Fan S; Zuo C; Sun H; Zhu H; Wang J; Tang S
Nat Commun; 2022 Nov; 13(1):7001. PubMed ID: 36385095
[TBL] [Abstract][Full Text] [Related]
10. Adaptor SKAP-55 binds p21 activating exchange factor RasGRP1 and negatively regulates the p21-ERK pathway in T-cells.
Schneider H; Wang H; Raab M; Valk E; Smith X; Lovatt M; Wu Z; Maqueira-Iglesias B; Strebhardt K; Rudd CE
PLoS One; 2008 Mar; 3(3):e1718. PubMed ID: 18320039
[TBL] [Abstract][Full Text] [Related]
11. The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties.
Qian X; Esteban L; Vass WC; Upadhyaya C; Papageorge AG; Yienger K; Ward JM; Lowy DR; Santos E
EMBO J; 2000 Feb; 19(4):642-54. PubMed ID: 10675333
[TBL] [Abstract][Full Text] [Related]
12. A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans.
Bongers G; Muniz LR; Pacer ME; Iuga AC; Thirunarayanan N; Slinger E; Smit MJ; Reddy EP; Mayer L; Furtado GC; Harpaz N; Lira SA
Gastroenterology; 2012 Sep; 143(3):730-740. PubMed ID: 22643351
[TBL] [Abstract][Full Text] [Related]
13. Vav1 transduces T cell receptor signals to the activation of the Ras/ERK pathway via LAT, Sos, and RasGRP1.
Reynolds LF; de Bettignies C; Norton T; Beeser A; Chernoff J; Tybulewicz VL
J Biol Chem; 2004 Apr; 279(18):18239-46. PubMed ID: 14764585
[TBL] [Abstract][Full Text] [Related]
14. RasGRP1 transmits prodifferentiation TCR signaling that is crucial for CD4 T cell development.
Priatel JJ; Chen X; Dhanji S; Abraham N; Teh HS
J Immunol; 2006 Aug; 177(3):1470-80. PubMed ID: 16849453
[TBL] [Abstract][Full Text] [Related]
15. RasGRP1 is essential for ras activation by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate in epidermal keratinocytes.
Sharma A; Luke CT; Dower NA; Stone JC; Lorenzo PS
J Biol Chem; 2010 May; 285(21):15724-30. PubMed ID: 20308057
[TBL] [Abstract][Full Text] [Related]
16. Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice.
Moran AE; Hunt DH; Javid SH; Redston M; Carothers AM; Bertagnolli MM
J Biol Chem; 2004 Oct; 279(41):43261-72. PubMed ID: 15294912
[TBL] [Abstract][Full Text] [Related]
17. Feedback activation of EGFR/wild-type RAS signaling axis limits KRAS
Feng J; Hu Z; Xia X; Liu X; Lian Z; Wang H; Wang L; Wang C; Zhang X; Pang X
Oncogene; 2023 May; 42(20):1620-1633. PubMed ID: 37020035
[TBL] [Abstract][Full Text] [Related]
18. RasGRP1 overexpression in T-ALL increases basal nucleotide exchange on Ras rendering the Ras/PI3K/Akt pathway responsive to protumorigenic cytokines.
Ksionda O; Melton AA; Bache J; Tenhagen M; Bakker J; Harvey R; Winter SS; Rubio I; Roose JP
Oncogene; 2016 Jul; 35(28):3658-68. PubMed ID: 26549032
[TBL] [Abstract][Full Text] [Related]
19. Targeted Sos1 deletion reveals its critical role in early T-cell development.
Kortum RL; Sommers CL; Alexander CP; Pinski JM; Li W; Grinberg A; Lee J; Love PE; Samelson LE
Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12407-12. PubMed ID: 21746917
[TBL] [Abstract][Full Text] [Related]
20. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
